Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MARK1 Antikörper (N-Term)

MARK1 Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB8545 unconjugated
Produktnummer ABIN391219
  • Target Alle MARK1 Antikörper anzeigen
    MARK1 (MAP/microtubule Affinity-Regulating Kinase 1 (MARK1))
    Bindungsspezifität
    • 9
    • 8
    • 8
    • 8
    • 7
    • 7
    • 6
    • 2
    • 2
    • 1
    • 1
    AA 6-40, N-Term
    Reaktivität
    • 62
    • 35
    • 12
    • 5
    • 5
    • 2
    • 2
    • 2
    • 2
    • 1
    Human, Maus
    Wirt
    • 62
    • 1
    Kaninchen
    Klonalität
    • 63
    Polyklonal
    Konjugat
    • 26
    • 7
    • 6
    • 6
    • 6
    • 6
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser MARK1 Antikörper ist unkonjugiert
    Applikation
    • 49
    • 44
    • 33
    • 11
    • 7
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Aufreinigung
    This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
    Immunogen
    This MARK1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 6-40 amino acids from the N-terminal region of human MARK1.
    Klon
    RB8545
    Isotyp
    Ig Fraction
    Top Product
    Discover our top product MARK1 Primärantikörper
  • Applikationshinweise
    WB: 1:1000. IHC-P: 1:10~50
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
    Haltbarkeit
    6 months
  • Hezel, Gurumurthy, Granot, Swisa, Chu, Bailey, Dor, Bardeesy, Depinho: "Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms." in: Molecular and cellular biology, Vol. 28, Issue 7, pp. 2414-25, (2008) (PubMed).

  • Target
    MARK1 (MAP/microtubule Affinity-Regulating Kinase 1 (MARK1))
    Andere Bezeichnung
    MARK1 (MARK1 Produkte)
    Synonyme
    MGC80341 antikoerper, MARK1 antikoerper, AW491150 antikoerper, B930025N23Rik antikoerper, Emk3 antikoerper, Par-1c antikoerper, mKIAA1477 antikoerper, mPar-1c antikoerper, MARK antikoerper, Par1c antikoerper, MAP/microtubule affinity-regulating kinase 1 S homeolog antikoerper, microtubule affinity regulating kinase 1 antikoerper, MAP/microtubule affinity-regulating kinase 1 antikoerper, MAP/microtubule affinity regulating kinase 1 antikoerper, mark1.S antikoerper, MARK1 antikoerper, mark1 antikoerper, Mark1 antikoerper
    Hintergrund
    MARK is a family of kinases that is known for its involvement in establishing cell polarity and in phosphorylating tau protein during Alzheimer neurodegeneration. Expression of MARK causes the phosphorylation of MAPs at their KXGS motifs, thereby detaching MAPs from the microtubules and thus facilitating the transport of particles. This occurs without impairing the intrinsic activity of motors because the velocity during active movement remains unchanged. In primary retinal ganglion cells, transfection with tau leads to the inhibition of axonal transport of mitochondria, APP vesicles, and other cell components which leads to starvation of axons and vulnerability against stress. This transport inhibition can be rescued by phosphorylating tau with MARK
    Molekulargewicht
    89003
    Gen-ID
    4139
    NCBI Accession
    NP_061120
    UniProt
    Q9P0L2
    Pathways
    SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
Sie sind hier:
Kundenservice